131 related articles for article (PubMed ID: 30001480)
1. Role of Activator Protein-1 Complex on the Phenotype of Human Osteosarcomas Generated from Mesenchymal Stem Cells.
Gambera S; Abarrategi A; Rodríguez-Milla MA; Mulero F; Menéndez ST; Rodriguez R; Navarro S; García-Castro J
Stem Cells; 2018 Oct; 36(10):1487-1500. PubMed ID: 30001480
[TBL] [Abstract][Full Text] [Related]
2. Generation of Osteosarcomas from a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem Cells.
Wang JY; Wu PK; Chen PC; Lee CW; Chen WM; Hung SC
Stem Cells Transl Med; 2017 Feb; 6(2):512-526. PubMed ID: 28191765
[TBL] [Abstract][Full Text] [Related]
3. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.
Rubio R; Abarrategi A; Garcia-Castro J; Martinez-Cruzado L; Suarez C; Tornin J; Santos L; Astudillo A; Colmenero I; Mulero F; Rosu-Myles M; Menendez P; Rodriguez R
Stem Cells; 2014 May; 32(5):1136-48. PubMed ID: 24446210
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells promote tumor engraftment and metastatic colonization in rat osteosarcoma model.
Tsukamoto S; Honoki K; Fujii H; Tohma Y; Kido A; Mori T; Tsujiuchi T; Tanaka Y
Int J Oncol; 2012 Jan; 40(1):163-9. PubMed ID: 21971610
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Tumor- and Bone Marrow-Derived Mesenchymal Stromal/Stem Cells from Patients with High-Grade Osteosarcoma.
Le Nail LR; Brennan M; Rosset P; Deschaseaux F; Piloquet P; Pichon O; Le Caignec C; Crenn V; Layrolle P; Hérault O; De Pinieux G; Trichet V
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29494553
[TBL] [Abstract][Full Text] [Related]
6. c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis.
Shimizu T; Ishikawa T; Sugihara E; Kuninaka S; Miyamoto T; Mabuchi Y; Matsuzaki Y; Tsunoda T; Miya F; Morioka H; Nakayama R; Kobayashi E; Toyama Y; Kawai A; Ichikawa H; Hasegawa T; Okada S; Ito T; Ikeda Y; Suda T; Saya H
Oncogene; 2010 Oct; 29(42):5687-99. PubMed ID: 20676132
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells in the osteosarcoma microenvironment: their biological properties, influence on tumor growth, and therapeutic implications.
Zheng Y; Wang G; Chen R; Hua Y; Cai Z
Stem Cell Res Ther; 2018 Jan; 9(1):22. PubMed ID: 29386041
[TBL] [Abstract][Full Text] [Related]
8. cFOS-SOX9 Axis Reprograms Bone Marrow-Derived Mesenchymal Stem Cells into Chondroblastic Osteosarcoma.
He Y; Zhu W; Shin MH; Gary J; Liu C; Dubois W; Hoover SB; Jiang S; Marrogi E; Mock B; Simpson RM; Huang J
Stem Cell Reports; 2017 Jun; 8(6):1630-1644. PubMed ID: 28552607
[TBL] [Abstract][Full Text] [Related]
9. Increased invasiveness of osteosarcoma mesenchymal stem cells induced by bone-morphogenetic protein-2.
Yang X; Wang YP; Liu FX; Zeng K; Qian MQ; Chen G; Shi L; Zhu GX
In Vitro Cell Dev Biol Anim; 2013 Apr; 49(4):270-8. PubMed ID: 23519562
[TBL] [Abstract][Full Text] [Related]
10. Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2.
Mohseny AB; Szuhai K; Romeo S; Buddingh EP; Briaire-de Bruijn I; de Jong D; van Pel M; Cleton-Jansen AM; Hogendoorn PC
J Pathol; 2009 Nov; 219(3):294-305. PubMed ID: 19718709
[TBL] [Abstract][Full Text] [Related]
11. Cabozantinib Affects Osteosarcoma Growth Through A Direct Effect On Tumor Cells and Modifications In Bone Microenvironment.
Fioramonti M; Fausti V; Pantano F; Iuliani M; Ribelli G; Lotti F; Pignochino Y; Grignani G; Santini D; Tonini G; Vincenzi B
Sci Rep; 2018 Mar; 8(1):4177. PubMed ID: 29520051
[TBL] [Abstract][Full Text] [Related]
12. Acquisition of stem associated-features on metastatic osteosarcoma cells and their functional effects on mesenchymal stem cells.
Álvarez MV; Gutiérrez LM; Auzmendi J; Correa A; Lazarowski A; Bolontrade MF
Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129522. PubMed ID: 31945406
[TBL] [Abstract][Full Text] [Related]
13. Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells.
Bonuccelli G; Avnet S; Grisendi G; Salerno M; Granchi D; Dominici M; Kusuzaki K; Baldini N
Oncotarget; 2014 Sep; 5(17):7575-88. PubMed ID: 25277190
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow-derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition.
Pietrovito L; Leo A; Gori V; Lulli M; Parri M; Becherucci V; Piccini L; Bambi F; Taddei ML; Chiarugi P
Mol Oncol; 2018 May; 12(5):659-676. PubMed ID: 29517849
[TBL] [Abstract][Full Text] [Related]
16. The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors.
Dani N; Olivero M; Mareschi K; van Duist MM; Miretti S; Cuvertino S; Patané S; Calogero R; Ferracini R; Scotlandi K; Fagioli F; Di Renzo MF
J Bone Miner Res; 2012 Jun; 27(6):1322-34. PubMed ID: 22367914
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone versus phorbol ester stimulation of activator protein-1 gene family members in rat osteosarcoma cells.
Koe RC; Clohisy JC; Tyson DR; Pulumati MR; Cook TF; Partridge NC
Calcif Tissue Int; 1997 Jul; 61(1):52-8. PubMed ID: 9192514
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3.
Tu B; Zhu J; Liu S; Wang L; Fan Q; Hao Y; Fan C; Tang TT
Oncotarget; 2016 Jul; 7(30):48296-48308. PubMed ID: 27340780
[TBL] [Abstract][Full Text] [Related]
19. Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas.
Papachristou DJ; Batistatou A; Sykiotis GP; Varakis I; Papavassiliou AG
Bone; 2003 Apr; 32(4):364-71. PubMed ID: 12689679
[TBL] [Abstract][Full Text] [Related]
20. A humanized bone microenvironment uncovers HIF2 alpha as a latent marker for osteosarcoma.
Wagner F; Holzapfel BM; Martine LC; McGovern J; Lahr CA; Boxberg M; Prodinger PM; Grässel S; Loessner D; Hutmacher DW
Acta Biomater; 2019 Apr; 89():372-381. PubMed ID: 30836200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
